期刊文献+

HPV16型E6变异体对HSIL锥切术后持续感染及复发的影响 被引量:3

The role of HPV type 16 E6 variant in persistent infection and recurrence of cervical HSILs after conization
下载PDF
导出
摘要 目的 :探索HPV16型E6变异体对HSIL锥切术后持续感染及复发的预警作用。方法:选取2011年5月至2012年6月本院HPV16型阳性、LEEP术后切缘阴性的HSIL患者100例,对其宫颈脱落细胞E6基因测序,术后随访2年。持续感染及复发者再次测序明确HPV16变异体。结果:100例均检测出变异体,81.0%为亚洲原型,14.0%为欧洲变异体,2.0%欧洲原型,3.0%非洲1变异体;亚洲原型锥切术后HPV16易清除(P<0.001);欧洲变异体T350G、A442C有更高的HPV16持续感染及复发相关性(P<0.001)。结论 :(1)HPV16变异体与HSIL发生密切相关;(2)上海浦东地区HPV16导致的HSIL多属于亚洲型变异体,锥切后HPV16易清除;(3)欧洲变异体E6 T350G/A442C可能有更高的锥切术后HPV16复发及持续感染相关性。 Objective To explore the role of humall papillomavims (HPV) type 16 E6 variants in the persistent infection and recurrence of the cervical high-grade squamous intraepithelial lesion (HSIL) after conization. Motheds During May to June 2012, lO0 HSIL patients with HPV16 positive but negative at the margin after Loop electrosurgical excision procedure (LEEP) were selected from Shanghai People's Hospital of Pudong District. The gene sequencing was done to the E6. The patients were followed up for 2 years. The E6 gene sequencing was done again to detect the HPV16 variants among those with persistent infections and recurrence. Results Among the 100 cases, E6 variants were detected, 81% of them HPV E6 variants Asian prototype, 14% European variant; 2% European prototype (EP) and 3% African variant 1. LEEP for Asian prototype was susceptible to the clearance of HPV16 (P 〈 0.001 ). The European variants of T350G, and A442C were correlated with persistent infection and recurrence (P 〈 0.001). Conclusion The HPV16 variant is closely related to the HSIL incidence. HSIL caused by HPV16 in Pudong New Area of Shanghai belong to the Asian type variant. The European variants of E6, T350G/A442C were likely related to the recurrence of HPVI6.
出处 《实用医学杂志》 CAS 北大核心 2015年第23期3906-3908,共3页 The Journal of Practical Medicine
基金 上海市卫生局科研基金资助项目(编号:20124485)
关键词 人乳头瘤病毒 高度鳞状上皮内病变 E6 变异体 Humall papillomavims (HPV) High-grade squamous intraepithelial lesion (HSIL) E6 Variant
  • 相关文献

参考文献12

  • 1Whyte J. HPV and cervical cancer: Latest developments [J]. Consultant, 2012,52:555-560.
  • 2Massad IS, Einstein MH, Huh WK, et al. 2012 updated con- sensus guidelines for the management of abnormal cervical can- cer screening tests and cancerprecursors [J]. Obstet Gynecol, 2013,121 (4) : 829-846.
  • 3Fuste P, Bellosillo B, Santamaria X, et al. HPV Determination in the Control After LEEP Due to CIN 2/3 : Prospective Study and Predictive Model [J]. Inte J Gynecol Path, 2009,28 (2): 120-126.
  • 4Katki HA, Schiffman M, Castle PE, et al . Five-year risk of re- currence after treatment of CIN 2, CIN 3, or AIS : performance of HPV and Pap cotesting in posttreatment management [J]. J Low Genit Tract, 2013,17(5 ) : S78-84.
  • 5张科,李淑英,侯灵彤,赵莹,张云茹,王玉娇.宫颈脱落细胞中人乳头瘤病毒16型整合状态及病毒载量分析[J].实用医学杂志,2014,30(2):196-198. 被引量:2
  • 6Gillison ML, Shah KV. Chapter 9: Role of mucosal human pa- pillomavirus in nongenital cancers [J]. J Natl Cancer Inst Mono- gr, 2003,31(1):57-65.
  • 7Wheeler CM, Hunt WC, Cuzick J, et al. The influence of type- specific human papillomavirus infections on the detection of cer- vical precancer and cancer : A population-based study of oppor- tunistic cervical screening in the United Stales [J]. Int J Can- cer, 2014,135(3) :624-634.
  • 8He I, Chan SY, Burk RD, et al. The genetic drift of human pa- pillomavirus type 16 is a means of reconstructing prehistoric viral spread and movement of ancient populations [J]. J Virol, 1993, 67 ( 11 ) :6413-6424.
  • 9Schiffman M, Rodriguez AC, Chen Z, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia [ J ]. Cancer Res, 2010,70(8) :3159-3169.
  • 10Nindl I, Rindfleisch K, Lotz B, et al. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer [J]. lnt J Cancer, 1999,82(3) :203-207.

二级参考文献7

  • 1Zur Hansen H. Papillomaviruses and cancer:from basic studies to clinical application[J].{H}Nature Reviews Cancer,2002,(05):342-350.
  • 2Hudelist G,Manavi M,Pischinger K I. Physical State and expression of HPV DNA in benign and dysplastie cervical tissue:diferent levels of viral integration are correlated with lesion grade[J].{H}Gynecologic Oncology,2004,(03):873-880.
  • 3Guo M,Sneige N,Silva E G. Distribution and viral load of eight oneogenic types of human papillomavirus(HPV)and HPV16 integration status in cervical intraepithelial neoplasia and carcinoma[J].{H}Modern Pathology,2007,(02):256-266.
  • 4Karlsen F,Kalantari M,Jenkins A. Use of Multiple PCR Sets for Optimal Detection of Human papillomavirus[J].{H}Journal of Clinical Microbiology,1996,(09):2095-2100.
  • 5Meissner J D. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki,SiHa and HeLa cervical carcinoma cell lines[J].{H}Journal of General Virology,1999,(Pt 7):1725-1733.
  • 6陈观娣,钱德英,李志刚,欧阳云雁.高危型人乳头瘤病毒-DNA检测在宫颈鳞状上皮内高度病变筛查中的价值[J].实用医学杂志,2009,25(9):1427-1429. 被引量:52
  • 7黄卓敏,江曼茹,王楚莹,姚吉龙,谢建生.Brd4与HPV-16病毒E2在宫颈脱落细胞中的表达及意义[J].实用医学杂志,2012,28(19):3198-3201. 被引量:7

共引文献1

同被引文献22

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部